Previously, Firehawk ® was approved to enter the India market, and has gained high recognition from physicians and patients with its excellent performance. Foxtrot ® NC approved in India has a total of 60 specifications, covering 10 diameters (2.2mm to 5.0mm) and six lengths (6mm, 8mm, 10mm, 12mm, 15mm and 20mm). Foxtrot ® NC has excellent crossability, trackability and pushability. Two radiopaque markers aid in the positioning of the balloon under fluoroscopy during procedures. Super hydrophilic coating allows the catheter to move freely in vessels and reach the narrow lesion area smoothly. Foxtrot ® NC is a low-compliant balloon catheter and has a short deflation time. The shaft has a combination of single lumen and dual lumens tubing and is made from high polymer material with high pressure resistance. Foxtrot ® Pro that gained the CDSCO approval has a total of 26 specifications, covering six diameters (1.5mm to 4.0mm) and five lengths (6mm, 10mm, 15mm, 20mm, and 25mm).įoxtrot ® NC is indicated for pre-dilation as well as post-dilation. It also features seamless connection by laser wielding technique as well as special soft-tip that make the balloon catheter tip more pliable. The product offers multiple solutions for complex diseases with excellent crossability and trackability Foxtrot ® Pro adopts internationally advanced new material and new 'stripe' hydrophilic coating which leads to excellent lubricity during tracking and enhanced stability during inflation. Firefighter™ that gained the regulatory approval in India has a total of 43 specifications, covering 12 diameters (1.0mm-4.0mm) and four lengths (6mm, 10mm, 15mm and 20mm).įoxtrot ® Pro is also indicated for pre-dilating the stenotic atherosclerotic lesions of coronary artery disease to facilitate the implantation of stent. Its ultra low profile allows two balloon catheters to be accommodated in a 5F guiding catheter, which facilitates physicians to adopt kissing balloon strategy. Firefighter™ features much smaller balloon crossing profile and softer material compared to competitors' products, leading to excellent crossability through stenotic and tortuous lesions. It can be used in combination with MicroPort ®'s in-house developed Firehawk ® Rapamycin Target Eluting Coronary Stent System ('Firehawk ®') to pre-dilate the lesion before the implantation of the stent. They are the first batch of balloon catheters of MicroPort ® that gained regulatory approval in India, marking the official entry of its new generation balloon catheter in the India market.įirefighter™ is a rapid exchange catheter, indicated for dilating the stenotic atherosclerotic lesions of coronary artery disease to improve myocardial perfusion in patient. ('MicroPort ®') gained the approval from India's Central Drugs Standard Control Organization ('CDSCO') for its in-house developed Firefighter™ PTCA Balloon Catheter ('Firefighter™'), FOXTROT™ NC PTCA Balloon Catheter ('FOXTROT™ NC'), and FOXTROT™ PRO PTCA Balloon Catheter ('FOXTROT™ PRO'). New Delhi, India - On December 27, Shanghai MicroPort Medical (Group) Co., Ltd.
0 Comments
Leave a Reply. |